長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【7446】東北化学薬品

【7446】東北化学薬品
化学工業薬品、臨床検査試薬。
類似企業：
【業界1位】 YUASA
【売上同水準】 南陽 オータケ


東証スタンダード
卸売
＞
工卸
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2026.09 2026/07/31 Q3予 35,600 ↑ +1.7% +1.7% 720 ↑ +35.8% +35.8% 820 ↑ +32.3% +32.3% 510 ↑ +18.6% +18.6%
2026.09 2026/05/01 Q2予 35,000 → 0.0% 0.0% 530 → 0.0% 0.0% 620 → 0.0% 0.0% 430 → 0.0% 0.0%
2026.09 2026/02/02 Q1予 35,000 → 0.0% 0.0% 530 → 0.0% 0.0% 620 → 0.0% 0.0% 430 → 0.0% 0.0%
2026.09 2025/11/14 当初予 35,000 - - - 530 - - - 620 - - - 430 - - -
2025.09 2025/11/14 実 34,442 ↑ +2.2% +2.2% 518 ↑ +23.3% +23.3% 595 ↑ +21.4% +21.4% 428 ↑ +38.1% +38.1%
2025.09 2025/07/31 Q3予 33,700 → 0.0% 0.0% 420 → 0.0% 0.0% 490 → 0.0% 0.0% 310 → 0.0% 0.0%
2025.09 2025/05/01 Q2予 33,700 → 0.0% 0.0% 420 → 0.0% 0.0% 490 → 0.0% 0.0% 310 → 0.0% 0.0%
2025.09 2025/02/03 Q1予 33,700 → 0.0% 0.0% 420 → 0.0% 0.0% 490 → 0.0% 0.0% 310 → 0.0% 0.0%
2025.09 2024/11/14 当初予 33,700 - - - 420 - - - 490 - - - 310 - - -
2024.09 2024/11/14 実 32,155 ↓ -0.4% -0.4% 353 ↓ -19.8% -19.8% 407 ↓ -16.9% -16.9% 237 ↓ -25.9% -25.9%
2024.09 2024/08/01 Q3予 32,300 → 0.0% 0.0% 440 → 0.0% 0.0% 490 → 0.0% 0.0% 320 → 0.0% 0.0%
2024.09 2024/05/01 Q2予 32,300 → 0.0% 0.0% 440 → 0.0% 0.0% 490 → 0.0% 0.0% 320 → 0.0% 0.0%
2024.09 2024/02/01 Q1予 32,300 → 0.0% 0.0% 440 → 0.0% 0.0% 490 → 0.0% 0.0% 320 → 0.0% 0.0%
2024.09 2023/11/13 当初予 32,300 - - - 440 - - - 490 - - - 320 - - -
2023.09 2023/11/13 実 35,094 ↑ +0.3% +0.3% 750 ↑ +27.1% +27.1% 808 ↑ +26.2% +26.2% 556 ↑ +32.4% +32.4%
2023.09 2023/08/01 Q3予 35,000 → 0.0% 0.0% 590 → 0.0% 0.0% 640 → 0.0% 0.0% 420 → 0.0% 0.0%
2023.09 2023/05/02 Q2予 35,000 → 0.0% 0.0% 590 → 0.0% 0.0% 640 → 0.0% 0.0% 420 → 0.0% 0.0%
2023.09 2023/02/01 Q1予 35,000 → 0.0% 0.0% 590 → 0.0% 0.0% 640 → 0.0% 0.0% 420 → 0.0% 0.0%
2023.09 2022/11/14 当初予 35,000 - - - 590 - - - 640 - - - 420 - - -
2022.09 2022/11/14 実 37,333 ↑ +5.2% +10.5% 944 ↑ +38.8% +63.3% 1,003 ↑ +37.6% +64.2% 657 ↑ +39.5% +51.7%
2022.09 2022/08/01 Q3予 35,500 ↑ +5.0% +5.0% 680 ↑ +17.6% +17.6% 729 ↑ +19.3% +19.3% 471 ↑ +8.8% +8.8%
2022.09 2022/05/06 Q2予 33,800 → 0.0% 0.0% 578 → 0.0% 0.0% 611 → 0.0% 0.0% 433 → 0.0% 0.0%
2022.09 2022/02/01 Q1予 33,800 → 0.0% 0.0% 578 → 0.0% 0.0% 611 → 0.0% 0.0% 433 → 0.0% 0.0%
2022.09 2021/11/12 当初予 33,800 - - - 578 - - - 611 - - - 433 - - -
2021.09 2021/11/12 実 36,221 ↑ +3.5% +13.9% 713 ↑ +30.8% +82.8% 758 ↑ +31.8% +78.4% 516 ↑ +35.8% +87.6%
2021.09 2021/08/02 修正予 35,000 ↑ +10.1% +10.1% 545 ↑ +39.7% +39.7% 575 ↑ +35.3% +35.3% 380 ↑ +38.2% +38.2%
2021.09 2021/05/06 Q2予 31,800 → 0.0% 0.0% 390 → 0.0% 0.0% 425 → 0.0% 0.0% 275 → 0.0% 0.0%
2021.09 2021/02/01 Q1予 31,800 → 0.0% 0.0% 390 → 0.0% 0.0% 425 → 0.0% 0.0% 275 → 0.0% 0.0%
2021.09 2020/11/13 当初予 31,800 - - - 390 - - - 425 - - - 275 - - -
2020.09 2020/11/13 実 31,040 ↓ -2.1% -2.1% 361 ↑ +14.2% +14.2% 410 ↑ +15.5% +15.5% 378 ↑ +75.8% +75.8%
2020.09 2020/08/03 Q3予 31,700 → 0.0% 0.0% 316 → 0.0% 0.0% 355 → 0.0% 0.0% 215 → 0.0% 0.0%
2020.09 2020/05/01 Q2予 31,700 → 0.0% 0.0% 316 → 0.0% 0.0% 355 → 0.0% 0.0% 215 → 0.0% 0.0%
2020.09 2020/02/03 Q1予 31,700 → 0.0% 0.0% 316 → 0.0% 0.0% 355 → 0.0% 0.0% 215 → 0.0% 0.0%
2020.09 2019/11/13 当初予 31,700 - - - 316 - - - 355 - - - 215 - - -
2019.09 2019/11/13 実 31,013 ↓ -2.8% -2.8% 283 ↓ -9.3% -9.3% 329 ↓ -3.2% -3.2% 221 ↑ +5.2% +5.2%
2019.09 2019/08/01 Q3予 31,900 → 0.0% 0.0% 312 → 0.0% 0.0% 340 → 0.0% 0.0% 210 → 0.0% 0.0%
2019.09 2019/05/08 Q2予 31,900 → 0.0% 0.0% 312 → 0.0% 0.0% 340 → 0.0% 0.0% 210 → 0.0% 0.0%
2019.09 2019/02/01 Q1予 31,900 → 0.0% 0.0% 312 → 0.0% 0.0% 340 → 0.0% 0.0% 210 → 0.0% 0.0%
2019.09 2018/11/14 当初予 31,900 - - - 312 - - - 340 - - - 210 - - -
2018.09 2018/11/14 実 31,730 ↓ -1.3% -1.3% 292 ↑ +11.5% +11.5% 333 ↑ +14.4% +14.4% 305 ↑ +8.9% +8.9%
2018.09 2018/08/01 Q3予 32,150 → 0.0% 0.0% 262 → 0.0% 0.0% 291 → 0.0% 0.0% 280 → 0.0% 0.0%
2018.09 2018/05/02 Q2予 32,150 → 0.0% 0.0% - - - - 291 → 0.0% 0.0% 280 → 0.0% 0.0%
2018.09 2018/02/01 Q1予 32,150 → 0.0% 0.0% 262 → 0.0% 0.0% 291 → 0.0% 0.0% 280 → 0.0% 0.0%
2018.09 2017/11/14 当初予 32,150 - - - 262 - - - 291 - - - 280 - - -
2017.09 2017/11/14 実 30,862 ↓ -2.0% -2.0% 202 ↓ -35.9% -35.9% 242 ↓ -29.9% -29.9% 133 ↓ -39.5% -39.5%
2017.09 2017/08/01 Q3予 31,500 → 0.0% 0.0% 315 → 0.0% 0.0% 345 → 0.0% 0.0% 220 → 0.0% 0.0%
2017.09 2017/05/02 Q2予 31,500 → 0.0% 0.0% 315 → 0.0% 0.0% 345 → 0.0% 0.0% 220 → 0.0% 0.0%
2017.09 2017/02/01 Q1予 31,500 → 0.0% 0.0% 315 → 0.0% 0.0% 345 → 0.0% 0.0% 220 → 0.0% 0.0%
2017.09 2016/11/14 当初予 31,500 - - - 315 - - - 345 - - - 220 - - -
2016.09 2016/11/14 実 30,097 ↓ -2.3% -2.3% 197 ↓ -29.6% -29.6% 232 ↓ -24.2% -24.2% 125 ↓ -3.8% -3.8%
2016.09 2016/08/01 Q3予 30,800 → 0.0% 0.0% 280 → 0.0% 0.0% 306 → 0.0% 0.0% 130 → 0.0% 0.0%
2016.09 2016/05/02 Q2予 30,800 → 0.0% 0.0% 280 → 0.0% 0.0% 306 → 0.0% 0.0% 130 → 0.0% 0.0%
2016.09 2016/02/01 Q1予 30,800 → 0.0% 0.0% 280 → 0.0% 0.0% 306 → 0.0% 0.0% 130 → 0.0% 0.0%
2016.09 2015/11/16 当初予 30,800 - - - 280 - - - 306 - - - 130 - - -
2015.09 2015/11/16 実 29,565 ↓ -4.3% -4.3% 205 ↓ -36.9% -36.9% 240 ↓ -30.4% -30.4% 159 ↓ -16.3% -16.3%
2015.09 2015/07/31 Q3予 30,900 → 0.0% 0.0% 325 → 0.0% 0.0% 345 → 0.0% 0.0% 190 → 0.0% 0.0%
2015.09 2015/05/01 Q2予 30,900 → 0.0% 0.0% 325 → 0.0% 0.0% 345 → 0.0% 0.0% 190 → 0.0% 0.0%
2015.09 2015/01/30 Q1予 30,900 → 0.0% 0.0% 325 → 0.0% 0.0% 345 → 0.0% 0.0% 190 → 0.0% 0.0%
2015.09 2014/11/14 当初予 30,900 - - - 325 - - - 345 - - - 190 - - -
2014.09 2014/11/14 実 29,667 - - - 263 - - - 290 - - - 146 - - -
シェア ツイート
ページトップへ戻る